Risk factors and early detection of joint damage in patients with psoriasis: a case–control study
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.17212 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Amin Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Psoriasis, Blood Sedimentation, Early Diagnosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Project.
Abstract (Originalsprache)
Background
Our aim was to target the unsatisfied need for early detection of the at‐risk population and determine the subgroup of patients whose psoriasis (PsO) could transform into psoriatic arthritis (PsA).
Methods
A retrospective and longitudinal case–control study was conducted at Beijing Chao‐yang Hospital. It included 75 patients who were clinically diagnosed with PsA in the case group and 345 who solely suffered from PsO without PsA in the control group. A variety of baseline covariates were gathered from every patient with PsO. Univariate and multivariate analyses and receiver operating characteristic (ROC) curves were used to identify underlying risk factors and determine whether it was necessary to examine the imaging of PsO patients.
Results
In multivariate logistic regression analysis, age ≥40 (odds ratio (OR): 1.04, 95% confidence interval (CI): 1.02–1.06, P < 0.01), nail involvement (OR: 1.17, 95% CI: 1.09–1.32, P < 0.01), erythrocyte sedimentation rate (ESR) (OR: 1.03, 95% CI: 1.01–1.06, P < 0.05) and elevated high‐sensitivity C‐reactive protein (hs‐CRP) (OR: 1.31, 95% CI: 1.13–1.53, P < 0.01) were perceived to be risk factors for the transformation from PsO into clinical PsA. By combining magnetic resonance imaging (MRI)‐detected enthesitis with tenosynovitis, combined predictors demonstrated better diagnostic efficacy, with an improvement in specificity (94.3% vs. 69%) and similarities in sensitivity (89% vs. 84.6%). The areas under the ROC curve (AUCs) amounted to 0.925 (95% CI: 0.882–0.967, P < 0.01) and 0.858 (95% CI: 0.814–0.903, P < 0.01).
Conclusions
It wa s identified that age ≥40, nail involvement, as well as an elevated ESR, and hs‐CRP served as independent risk factors for PsO transforming into PsA. Additionally, MRI provides additional value for the early recognition of PsA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Department of Dermatology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
- Department of Radiology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
- Department of Rheumatology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
- Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Photomedicine Laboratory, Institute of Precision Medicine, Tsinghua University, Beijing, China.
ORCID-Profile: Amin Yao
Förderung
- Beijing Municipal Science and Technology Project
Zitieren
APA
Yao, A., Wang, L., Qi, F., Li, J., Meng, J., Jiang, T., Zhao, Y., & He, Y. (2024). Risk factors and early detection of joint damage in patients with psoriasis: a case–control study. International Journal of Dermatology. https://doi.org/10.1111/ijd.17212
Vancouver
Yao A, Wang L, Qi F, Li J, Meng J, Jiang T, et al. Risk factors and early detection of joint damage in patients with psoriasis: a case–control study. International Journal of Dermatology. 2024. doi:10.1111/ijd.17212
BibTeX
@article{Yao2024,
author = {Yao, Amin and Wang, Li and Qi, Fei and Li, Jialu and Meng, Juan and Jiang, Tao and Zhao, Yi and He, Yanling},
title = {Risk factors and early detection of joint damage in patients with psoriasis: a case–control study},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.17212}
}
EUVIMED